Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Cannabis

Page 43
  1. Dec 22, 2025 · 07:00 · TGIF

    1933 Industries Achieves Positive Income in Q1 2026, Marking Third Consecutive Profitable Quarter

    1933 Industries Achieves Positive Income in Q1 2026, Marking Third Consecutive Profitable Quarter

    01
  2. Dec 22, 2025 · 03:10 · TGIF

    SEDAR Interim Financial Statements

    SEDAR Interim Financial Statements

    02
  3. Dec 19, 2025 · 18:21 · CWEB

    Charlotte's DeFloria talks U.S. pot reclassification

    Charlotte's DeFloria talks U.S. pot reclassification

    03
  4. Dec 19, 2025 · 18:10 · VREO

    Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze

    Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze

    04
  5. Dec 19, 2025 · 16:32 · LABS

    Medipharm welcomes U.S. reclassification of cannabis

    Medipharm welcomes U.S. reclassification of cannabis

    05
  6. Dec 19, 2025 · 14:46 · CURA

    Curaleaf cancels acquisition of Cannabist assets

    Curaleaf cancels acquisition of Cannabist assets

    06
  7. Dec 19, 2025 · 14:18 · AVCN

    Avicanna applauds U.S. reclassification of cannabis

    Avicanna applauds U.S. reclassification of cannabis

    07
  8. Dec 19, 2025 · 11:23 · CWEB

    Presidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Development

    Presidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Development

    08
  9. Dec 19, 2025 · 08:45 · LABS

    Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

    Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

    09
  10. Dec 19, 2025 · 07:45 · CURA

    Curaleaf Announces Termination of Equity Purchase Agreement with The Cannabist Company

    Curaleaf Announces Termination of Equity Purchase Agreement with The Cannabist Company

    10
  11. Dec 19, 2025 · 07:30 · AVCN

    Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update

    Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update

    11
  12. Dec 19, 2025 · 05:03 · FNT

    Fluent welcomes rescheduling of cannabis to Schedule 3

    Fluent welcomes rescheduling of cannabis to Schedule 3

    12
  13. Dec 18, 2025 · 19:32 · LEEF

    LEEF Brands Comments on Federal Cannabis Rescheduling and Potential to Participate in Nationwide CBD Program

    LEEF Brands Comments on Federal Cannabis Rescheduling and Potential to Participate in Nationwide CBD Program

    13
  14. Dec 18, 2025 · 18:52 · CBST

    The Cannabist Company Announces Agreement for the Sale of Virginia Assets to an Affiliate of Millstreet following Go-Shop

    The Cannabist Company Announces Agreement for the Sale of Virginia Assets to an Affiliate of Millstreet following Go-Shop

    14
← Newer Older →